Table 2

Therapeutic regimen of all trials included in the meta-analysis

Study (reference)‡		Radiotherapy					Chemotherapy		Surgery
Study (reference)‡		Total dose (Gy)	Fractions (No/days)	Daily dose (Gy)	BED >(Gy)	BED corrected by time (Gy)	Drugs	Dosage >(mg/m²)	Schedules >(day)	Interval between end of irradiation and surgery (weeks)
*Tpot _squamo = 4.5 days³³; †Tpot_adeno = 6 days,³³ α = 0.3
BED, biological equivalent dose; CDDP, cisplatin; BLM, bleomycin; 5-FU, 5-fluorouracil; VNB, vinblastin.
‡For expansion of the study names, see corresponding reference.
1	Nygaard et al¹²	35	20/28	1.75	41.12	26.7*	CDDP	20	1–5; 15–19	3
							BLM	5
2	Le Prise et al¹³	20	10/12	2	24	17.8*	CDDP
							5FU	100	1; 21	2.5
								600	2–5; 22–25
3	Apinop et al¹⁴	40	20/28	2	48	33.6*	CDDP	100	1; 29	4
							5FU	1000	1–4;29–32
4	Walsh et al¹⁵	40	15/21	2.67	50.7	42.6†	CDDP	75	7;42	2
							5FU	15 mg/kg	1–5;36–40
5	Bosset et al¹⁶	37	10/24	3.7	50.7	38.4*	CDDP	80	0–2;19–21	2–4
6	Urba et al¹⁷	45	30/21	1.5×2	51.7	43.6† >adenoca.	CDDP	20	1–5;17–21	3
						40.9* >squamo.	5FU	300	1–21
							VNB	1	1–4;17–20